Next Article in Journal
Radioligands for Tropomyosin Receptor Kinase (Trk) Positron Emission Tomography Imaging
Previous Article in Journal
Natural Compounds and Derivatives as Ser/Thr Protein Kinase Modulators and Inhibitors
Previous Article in Special Issue
Radiolabelled Aptamers for Theranostic Treatment of Cancer
Article Menu

Export Article

Open AccessEditorial
Pharmaceuticals 2019, 12(1), 6;

Aptamer-Based Diagnostics and Therapeutics

School of Medicine Deakin University, Geelong, Victoria 3128, Australia
Centre for Molecular and Medical Research, Deakin University, Geelong, Victoria 3128, Australia
Received: 26 December 2018 / Accepted: 28 December 2018 / Published: 2 January 2019
(This article belongs to the Special Issue Aptamer-Based Diagnostics and Therapeutics)
Full-Text   |   PDF [150 KB, uploaded 2 January 2019]
Note: In lieu of an abstract, this is an excerpt from the first page.


Aptamers were first described almost 30 years ago, with the publication of three separate research papers describing how a randomized library of RNA sequences could be incubated with a target to find a sequence that specifically binds via van der Waals forces, covalent and hydrogen bonding, and not Watson Crick base pairing [...] View Full-Text
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Shigdar, S. Aptamer-Based Diagnostics and Therapeutics. Pharmaceuticals 2019, 12, 6.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top